52463-33-9 Usage
Uses
Used in Pharmaceutical Industry:
2,6-Naphthyridine, 3-chlorois used as a building block in organic synthesis for the development of pharmaceutical intermediates. Its unique structure and properties contribute to the creation of new drugs, enhancing the therapeutic options available in the market.
Used in Agrochemical Industry:
In the agrochemical industry, 2,6-naphthydridine, 3-chlorois employed as a precursor in the synthesis of various agrochemicals. Its role in chemical synthesis allows for the development of new compounds that can be used in crop protection and other agricultural applications.
Used in Dye Industry:
2,6-Naphthyridine, 3-chlorois also used as a component in the production of dyes. Its chemical properties make it suitable for the creation of new dye formulations, expanding the range of colors and properties available in the dye industry.
Used in Organic Chemistry Research:
As a precursor in chemical synthesis, 2,6-naphthydridine, 3-chlorois valuable in the field of organic chemistry. Researchers use 2,6-NAPHTHYRIDINE, 3-CHLORO- to explore new reaction pathways and develop innovative synthetic methods, furthering the understanding of organic chemistry and its applications.
Check Digit Verification of cas no
The CAS Registry Mumber 52463-33-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,4,6 and 3 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 52463-33:
(7*5)+(6*2)+(5*4)+(4*6)+(3*3)+(2*3)+(1*3)=109
109 % 10 = 9
So 52463-33-9 is a valid CAS Registry Number.
52463-33-9Relevant academic research and scientific papers
METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS
-
Paragraph 1325; 1329, (2021/11/06)
The subject matter described herein is directed to ferroportin inhibitor compounds of Formula (I) and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds, and methods of administering the compounds for prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, particularly iron overload states, such as thalassemia, sickle cell disease and hemochromatosis, and also kidney injuries.
